Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study-Reference-Cited by-同舟云学术

Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study

Published:2023-10-21 Issue:1 Volume:29 Page:55-63
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Kagawa Hirokazu,Urabe Fumihiko^ORCID,Kiuchi Yuria,Katsumi Kota,Yamaguchi Ryotaro,Suhara Yushi,Yoshihara Kentaro,Goto Yuma,Sadakane Ibuki,Yata Yuji,Saito Shun,Kurawaki Shiro,Ajisaka Shino,Miyajima Keiichiro,Takahashi Kazuhiro,Iwatani Kosuke,Imai Yu,Sakanaka Keigo,Nakazono Minoru,Kurauchi Takashi,Kayano Sotaro,Onuma Hajime,Aikawa Koichi,Yanagisawa Takafumi,Tashiro Kojiro,Tsuzuki Shunsuke,Furuta Akira,Miki Jun,Kimura Takahiro,

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02424-9.pdf

Reference11 articles.

1. Redrow GP, Matin SF (2016) Upper tract urothelial carcinoma: epidemiology, high risk populations and detection. Minerva Urol Nefrol 68(4):350–358

2. Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523–1525

3. Favaretto RL, Shariat SF, Chade DC et al (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58(4):574–580

4. Lughezzani G, Burger M, Margulis V et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100–114

5. Birtle A, Johnson M, Chester J et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232):1268–1277

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution;International Journal of Clinical Oncology;2024-09-12

2. Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomes;Japanese Journal of Clinical Oncology;2024-06-26

3. Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study;Clinical Genitourinary Cancer;2024-06

4. Letter to the editor for the article “Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy”;World Journal of Urology;2024-05-02

5. Re: Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis;BJU International;2024-03-14